Orexo
Develops pharmaceuticals and digital therapies for substance use and mental health.
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
Description
Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-11-16 08:00 |
Orexo meddelar nya försäljningsdata för Abstral™ från partnern ProStrakan samt …
|
Swedish | 99.0 KB | ||
| 2010-11-16 08:00 |
Orexo announces new sales figures for Abstral™ from its partner ProStrakan and …
|
English | 7.6 KB | ||
| 2010-11-10 08:01 | English | 243.3 KB | |||
| 2010-11-10 08:00 | Swedish | 235.0 KB | |||
| 2010-10-27 12:00 |
Orexo stärker dotterbolaget Kibion genom att rekrytera Petter Bäckgren som VD
|
Swedish | 73.5 KB | ||
| 2010-10-27 12:00 |
Orexo strengthens its subsidiary Kibion by recruiting Petter Bäckgren as CEO
|
English | 85.1 KB | ||
| 2010-10-22 16:00 |
Valberedning inför Orexos årsstämma 2011 och finansiell kalender 2010/2011
|
Swedish | 107.1 KB | ||
| 2010-10-22 16:00 |
Nomination Committee prior to Orexo’s Annual General Meeting 2011 and Financial…
|
English | 111.3 KB | ||
| 2010-09-16 08:00 |
Orexo tecknar avtal för Abstral™ i Mellanöstern och Afrika
|
Swedish | 99.5 KB | ||
| 2010-09-16 08:00 |
Orexo signs agreement for Abstral™ for the Middle East and Africa
|
English | 10.1 KB | ||
| 2010-09-07 08:15 | English | 79.1 KB | |||
| 2010-09-07 08:15 | Swedish | 73.3 KB | |||
| 2010-08-27 08:00 | Swedish | 72.6 KB | |||
| 2010-08-27 08:00 | English | 75.1 KB | |||
| 2010-08-26 17:30 | English | 70.5 KB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orexo
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
